Ovarian Cancer Flashcards
1
Q
Acceptable Recurrence Therapies for Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer
Preferred agents
Platinum-Sensitive Disease
A
Carboplatin Carboplatin/docetaxel Carboplatin/gemcitabine Carboplatin/gemcitabine/bevacizumab (category 2B) Carboplatin/liposomal doxorubicin (category 1) Carboplatin/paclitaxel (category 1) Carboplatin/paclitaxel (weekly) Cisplatin Cisplatin/gemcitabine
2
Q
Acceptable Recurrence Therapies for Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer
Preferred agents
Platinum-Resistant Disease
A
Docetaxel Etoposide, oral Gemcitabine Liposomal doxorubicin Liposomal doxorubicin/bevacizumab Paclitaxel (weekly)14 ± pazopanib Paclitaxel (weekly)/bevacizumab Topotecan Topotecan/bevacizumab
3
Q
Acceptable Recurrence Therapies for Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer
Other Potentially Active Agents
A
Altretamine Capecitabine Cyclophosphamide Doxorubicin Ifosfamide Irinotecan Melphalan Oxaliplatin Paclitaxel Paclitaxel, albumin bound (nab-paclitaxel) Pemetrexed Vinorelbine
4
Q
Acceptable Recurrence Therapies For Malignant Germ Cell
A
Potentially Curative Therapy:
High-dose chemotherapy
TIP (paclitaxel, ifosfamide, cisplatin)
Palliative Therapy Only: Cisplatin/etoposide Docetaxel Docetaxel/carboplatin Paclitaxel Paclitaxel/ifosfamide Paclitaxel/carboplatin Paclitaxel/gemcitabine VIP (etoposide, ifosfamide, cisplatin) VeIP (vinblastine, ifosfamide, cisplatin) VAC (vincristine, dactinomycin, cyclophosphamide) TIP
5
Q
Acceptable Recurrence Therapies For
Malignant Sex Cord Stromal tumors
A
Paclitaxel
Paclitaxel/ifosfamide
Paclitaxel/carboplatin
VAC
